Ignacio Garcia-Ribas

Ignacio Garcia-Ribas is a seasoned medical professional with extensive experience in oncology drug development. Currently serving as Senior Medical Director at Oncomatryx Biopharma since March 2022 and as Senior Consultant and Chief Medical Officer at Cantargia AB since February 2020, Ignacio has held significant roles in multiple organizations. Prior positions include Senior Medical Director at Takeda Oncology, where Ignacio acted as Global Clinical Lead on several Phase 1/2 programs focused on immune-oncology, and Project Head at Sanofi overseeing early oncology pipeline molecules and clinical trials. Ignacio's career began at Eli Lilly and Company, contributing to early drug development in oncology. Ignacio holds a PhD in Cancer Gene Therapy and is a specialist in Medical Oncology, supported by an MD from Universidad Autónoma de Madrid.